HISTOGENICS CORP — Form D

HISTOGENICS CORP of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2011-05-26. $34.3M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (39)

Showing 25 of 39 people.

NameRoleLocation
Patrick JB FortuneDirectorBoston, MA
Michael JB LewisDirector2005 Neuchatel 5, V8
Philip JB PressDirectorLondon W1S 2YZ, X0
Dominic JB RedfernDirectorLondon, X0
Harry JB ReinDirectorNorwalk, CT
Kirk JB AndrianoExecutive OfficerWaltham, MA
Brian JB CallahanExecutive OfficerWaltham, MA
Laurence JB TarrantExecutive OfficerWaltham, MA
Garheng KongDirectorSeattle, WA
Kevin RakinDirectorNew Haven, CT
Peter GreenleafDirectorDurham, NC
Peter GreenleafExecutive OfficerDurham, NC
Patrick O'DonnellDirectorPittsburgh, PA
Patrick O'DonnellExecutive OfficerPittsburgh, PA
John JohnsonDirectorChanhassen, MN
Michael LewisDirectorBoulder, CO
Jonathan J LieberDirectorHouston, TX
Adam GridleyDirectorLexington, MA
Adam GridleyExecutive OfficerLexington, MA
Ramesh KumarDirectorCambridge, MA
Kevin McArdleExecutive OfficerBoston, MA
Manish B PottiDirectorMalvern, PA
Sanjay B SubramanianExecutive OfficerMalvern, PA
Suha B TaspolatogluDirectorMalvern, PA
Shankar MusunuriDirectorMalvern, PA

Other filings by this issuer (6)

FiledFormOfferingSold
2020-05-07D$395$395
2020-05-07D$14.3M$14.3M
2016-10-12D$30.0M$30.0M
2014-01-06D$20.6M$10.3M
2012-11-26D/A$58.3M$37.6M
2012-07-27D$58.0M$37.5M

More